Miranda Smith

Researchers have revealed the final results of the REDUC Part B clinical trial to reduce the HIV reservoir in a presentation at the Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. Led by Associate Professor Ole Søgaard from Aarhus University Hospital, Denmark, the REDUC Part B trial explored the so-called “shock and kill” approach…

Christopher Kelly

Despite billions of dollars spent and some of the world’s best brains on the case, there is still no vaccine to protect against HIV. But, as Christopher Kelly reports, recent discoveries have recharged researchers’ efforts. HIV was isolated and identified in 1985. At the time, US health officials voiced confidence that a vaccine would be…

Miranda Smith

Research published this month in Nature suggests that ongoing HIV replication is responsible for maintaining a virus stockpile in lymphoid tissues even when treatment makes the virus undetectable in blood. Taking sequential viral sequences from blood and lymph nodes in three patients on ART, Lorenzo-Redondo and colleagues looked at the genetic code of the virus…

Supported by

Supported by the National Institute Of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI096109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

About NAPWHA

Founded in 1989, The National Association of People with HIV Australia (NAPWHA) is Australia’s peak non-government organisation representing community-based groups of people living with HIV (PLHIV).